Clinical Trial Update: Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating efficacy and safety of JMT103 in giant cell tumor of bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• JMT103

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Giant Cell Tumor of Bone | Phase 1, Phase 2 | Status: UNKNOWN